Shankhapushpi (Convolvulus pluricaulis Choisy): Validation of the Ayurvedic therapeutic claims through contemporary studies

Hetal Amin, Rohit Sharma, Mahesh Vyas, P. K. Prajapati, Kartar Dhiman

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Shankhapushpi (Convolvulus pluricaulis Choisy, CP) is an extremely versatile plant, commonly prescribed as nootropic (medhya), rejuvenator, nervine tonic in epilepsy, insanity and possesses wide range of therapeutic attributes. Since it is an essential ingredient of myriad popular Ayurvedic monoherbal or polyherbal preparations, it is commercially quite exploitable. Although CP exhibits a wide range of therapeutic attributes, only scattered information exploring the curative potential of CP is available, and there is a need to assemble it. Therefore, to revalidate the Ayurvedic therapeutic claims of Shankhapushpi in light of contemporary experimental and clinical studies, this study was carried out. Information was extracted from various Ayurvedic literature viz. Brihattrayi (Charaka Samhita, Sushruta Samhita and Ashtanga Hridaya) and Nighantu (lexicon). Online studies available on Convolvulus pluricaulis Choisy published in Pubmed, Scopemed, Pubmed Central Databases, Dhara online database and other allied databases were also rationally reviewed and documented in the present review. The current work appears to be the first of its kind and can be considered a reference standard for future studies.

Original languageEnglish
Pages (from-to)193-200
Number of pages8
JournalInternational Journal of Green Pharmacy
Issue number4
StatePublished - 1 Oct 2014
Externally publishedYes


  • Ayurveda
  • Convolvulus pluricaulis
  • shankhapushpi

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science


Dive into the research topics of 'Shankhapushpi (Convolvulus pluricaulis Choisy): Validation of the Ayurvedic therapeutic claims through contemporary studies'. Together they form a unique fingerprint.

Cite this